Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

18F-DOPA II - PET Imaging Optimization — Stella

Home/Congenital Hyperinsulinism/18F-DOPA II - PET Imaging Optimization

View on ClinicalTrials.gov

Recruiting

Back to Congenital Hyperinsulinism trials

18F-DOPA II - PET Imaging Optimization

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Canada

WC Mackenzie Health Science Centre / University of Alberta Hospital, Edmonton, Alberta

Key details

Phase

Large-scale testing

Sponsor

University of Alberta

Enrollment target

~800 participants

Started

January 2021

Primary completion

December 2027

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.